Loading...
Loading...
BDX| Name | Value |
|---|---|
| Revenues | 4,990.0M |
| Cost of Revenue | 2,683.0M |
| Gross Profit | 2,307.0M |
| Operating Expense | 1,592.0M |
| Operating I/L | 715.0M |
| Other Income/Expense | -215.0M |
| Interest Income | 48.0M |
| Pretax | 500.0M |
| Income Tax Expense | 13.0M |
| Net Income/Loss | 487.0M |
Becton, Dickinson and Company is a global leader in the development, manufacturing, and sale of medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry. The company's revenue is generated through its BD Medical segment, offering a wide range of medical products including IV catheters, drug delivery systems, diabetes care products, and sharps disposal systems; BD Life Sciences segment, providing specimen collection products, diagnostic assays, and laboratory automation products; and BD Interventional segment, offering surgical and interventional products for hernia repair, infection prevention, and urology care.
